SM
ALLR

Sabby Management’s Allarity Therapeutics ALLR Stock Holding History

Sabby Management’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-599
Closed -$268K – 57
2023
Q3 		$268K Buy
+599
New +$768K 0.2% 29

Other funds holding ALLR

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sabby Management's ALLR Position: Q4 2023 in Review

Sabby Management sold out of Allarity Therapeutics (ALLR) in Q4 2023, closing a stake of 599 shares — an estimated $268K sold.

Sabby Management first reported a position in ALLR in Q3 2023 and held it in 1 quarter. The position peaked at $268K in Q3 2023. 3 funds tracked by Wall St. Rank hold ALLR as of Q4 2023.

  • Sabby Management reported no remaining Allarity Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Sabby Management sold 599 Allarity Therapeutics shares in Q4 2023, an estimated $268K.
  • Sabby Management first reported a position in Allarity Therapeutics in Q3 2023 and held it in 1 quarter.
  • Sabby Management's Allarity Therapeutics position peaked at $268K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q4 2023.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.